Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood

Abstract The objective of this study was to evaluate whether juvenile fluoxetine (FLX) exposure induces long-term changes in baseline responses to anxiety-inducing environments, and if so, whether its re-exposure in adulthood would ameliorate this anxiety-like phenotype. An additional goal was to as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Francisco J. Flores-Ramirez, Anapaula Themann, Jorge A. Sierra-Fonseca, Israel Garcia-Carachure, Samuel A. Castillo, Minerva Rodriguez, Omar Lira, Joshua Preciado-Piña, Brandon L. Warren, Alfred J. Robison, Sergio D. Iñiguez
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/80c4ded134d041aa88cdd77b4d2e9863
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:80c4ded134d041aa88cdd77b4d2e9863
record_format dspace
spelling oai:doaj.org-article:80c4ded134d041aa88cdd77b4d2e98632021-12-02T18:15:25ZAdolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood10.1038/s41598-021-87378-62045-2322https://doaj.org/article/80c4ded134d041aa88cdd77b4d2e98632021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87378-6https://doaj.org/toc/2045-2322Abstract The objective of this study was to evaluate whether juvenile fluoxetine (FLX) exposure induces long-term changes in baseline responses to anxiety-inducing environments, and if so, whether its re-exposure in adulthood would ameliorate this anxiety-like phenotype. An additional goal was to assess the impact of adolescent FLX pretreatment, and its re-exposure in adulthood, on serotonin transporters (5-HTT) and brain-derived-neurotrophic-factor (BDNF)-related signaling markers (TrkB-ERK1/2-CREB-proBDNF-mBDNF) within the hippocampus and prefrontal cortex. To do this, female C57BL/6 mice were exposed to FLX in drinking water during postnatal-days (PD) 35–49. After a 21-day washout-period (PD70), mice were either euthanized (tissue collection) or evaluated on anxiety-related tests (open field, light/dark box, elevated plus-maze). Juvenile FLX history resulted in a persistent avoidance-like profile, along with decreases in BDNF-signaling markers, but not 5-HTTs or TrkB receptors, within both brain regions. Interestingly, FLX re-exposure in adulthood reversed the enduring FLX-induced anxiety-related responses across all behavioral tasks, while restoring ERK2-CREB-proBDNF markers to control levels and increasing mBDNF within the prefrontal cortex, but not the hippocampus. Collectively, these results indicate that adolescent FLX history mediates neurobehavioral adaptations that endure into adulthood, which are indicative of a generalized anxiety-like phenotype, and that this persistent effect is ameliorated by later-life FLX re-exposure, in a prefrontal cortex-specific manner.Francisco J. Flores-RamirezAnapaula ThemannJorge A. Sierra-FonsecaIsrael Garcia-CarachureSamuel A. CastilloMinerva RodriguezOmar LiraJoshua Preciado-PiñaBrandon L. WarrenAlfred J. RobisonSergio D. IñiguezNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Francisco J. Flores-Ramirez
Anapaula Themann
Jorge A. Sierra-Fonseca
Israel Garcia-Carachure
Samuel A. Castillo
Minerva Rodriguez
Omar Lira
Joshua Preciado-Piña
Brandon L. Warren
Alfred J. Robison
Sergio D. Iñiguez
Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
description Abstract The objective of this study was to evaluate whether juvenile fluoxetine (FLX) exposure induces long-term changes in baseline responses to anxiety-inducing environments, and if so, whether its re-exposure in adulthood would ameliorate this anxiety-like phenotype. An additional goal was to assess the impact of adolescent FLX pretreatment, and its re-exposure in adulthood, on serotonin transporters (5-HTT) and brain-derived-neurotrophic-factor (BDNF)-related signaling markers (TrkB-ERK1/2-CREB-proBDNF-mBDNF) within the hippocampus and prefrontal cortex. To do this, female C57BL/6 mice were exposed to FLX in drinking water during postnatal-days (PD) 35–49. After a 21-day washout-period (PD70), mice were either euthanized (tissue collection) or evaluated on anxiety-related tests (open field, light/dark box, elevated plus-maze). Juvenile FLX history resulted in a persistent avoidance-like profile, along with decreases in BDNF-signaling markers, but not 5-HTTs or TrkB receptors, within both brain regions. Interestingly, FLX re-exposure in adulthood reversed the enduring FLX-induced anxiety-related responses across all behavioral tasks, while restoring ERK2-CREB-proBDNF markers to control levels and increasing mBDNF within the prefrontal cortex, but not the hippocampus. Collectively, these results indicate that adolescent FLX history mediates neurobehavioral adaptations that endure into adulthood, which are indicative of a generalized anxiety-like phenotype, and that this persistent effect is ameliorated by later-life FLX re-exposure, in a prefrontal cortex-specific manner.
format article
author Francisco J. Flores-Ramirez
Anapaula Themann
Jorge A. Sierra-Fonseca
Israel Garcia-Carachure
Samuel A. Castillo
Minerva Rodriguez
Omar Lira
Joshua Preciado-Piña
Brandon L. Warren
Alfred J. Robison
Sergio D. Iñiguez
author_facet Francisco J. Flores-Ramirez
Anapaula Themann
Jorge A. Sierra-Fonseca
Israel Garcia-Carachure
Samuel A. Castillo
Minerva Rodriguez
Omar Lira
Joshua Preciado-Piña
Brandon L. Warren
Alfred J. Robison
Sergio D. Iñiguez
author_sort Francisco J. Flores-Ramirez
title Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
title_short Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
title_full Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
title_fullStr Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
title_full_unstemmed Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
title_sort adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female c57bl/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/80c4ded134d041aa88cdd77b4d2e9863
work_keys_str_mv AT franciscojfloresramirez adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT anapaulathemann adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT jorgeasierrafonseca adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT israelgarciacarachure adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT samuelacastillo adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT minervarodriguez adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT omarlira adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT joshuapreciadopina adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT brandonlwarren adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT alfredjrobison adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
AT sergiodiniguez adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood
_version_ 1718378403197878272